Clinical Trial: Supplemental Hydrogen Plus PQQ for Mitochondrial Biomarkers and Brain Function in Elderly With Mild Cognitive Impairment
Study Status: Completed
Recruit Status: RECRUITING
Condition: Age-associated Memory Impairment
Study Type: INTERVENTIONAL
Official Title: The Effects of Six-week Hydrogen Plus Pyrroloquinoline Quinone (PQQ) Intake on Mitochondrial Biomarkers, Brain Metabolism and Cognition in the Elderly With Mild Cognitive Impairment
Brief Summary:
The goal of this randomized controlled double-blind parallel-group interventional trial is to evaluate the effects of dietary supplementation with molecular hydrogen and pyrroloquinoline quinone in elderly.The main questions it aims to answer are: (1) whether the supplementation affects biomarkers of mitochondrial function in serum, and (2) whether the supplementation affects congition and brain metabolism.The participants will be subjected to take the dietary supplement during 6 weeks.
Read more